Civi Biopharma

Site is undergoing maintenance

United States · Founded 2017 · $89.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$89.0M
Last Round
$49.0M Venture RoundMay 2018
Rounds
2

About

CiVi Biopharma is a clinical-stage biotechnology company developing novel cardiovascular and metabolic therapies for patients with unmet medical needs. Its pipeline includes intravenous iloprost for severe frostbite through Eicos Sciences and CiVi 008, an oral PCSK9 therapy intended for cardiovascular-disease treatment and prevention.

Summary

Civi Biopharma is a Biotech company based in United States, founded in 2017. It has raised $89.0M in total across 2 rounds, most recently a $49.0M Venture Round round in May 2018. Investors include Boxer Capital and Tavistock Life Sciences.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMay 2018
$49.0M

Sign up to see all 2 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Civi Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/civi-biopharma"><img src="https://indexed.vc/api/badge/company/civi-biopharma" alt="Civi Biopharma on Indexed.vc" width="260" height="76" /></a>